CV Risk Remains High After Stopping Vioxx, Yale University School Of Medicine Study

Published: Dec 15, 2010

MedPageToday -- Even after patients stopped taking the painkiller rofecoxib (Vioxx) when it was pulled from the market, their risk of cardiovascular events remained high, researchers reported.

Back to news